BOTELLA, Gabriel Martinez,HARRISON, Boyd L.,ROBICHAUD, Albert Jean,SALITURO, Francesco G.,BERESIS, Richard Thomas
申请号：
EP20140785712
公开号：
EP2986623(B1)
申请日:
2014.04.17
申请国别(地区):
欧洲专利局
年份:
2018
代理人:
摘要：
and pharmaceutically acceptable salts thereof; wherein , R1, R2, R3a, R3b, R4a, R4b, R5, R6, and R7 are as defined herein. Such compounds are contemplated useful for the prevention and treatment of a variety of CNS-related conditions, for example, treatment of sleep disorders, mood disorders, schizophrenia spectrum disorders, convulsive disorders, disorders of memory and/or cognition, movement disorders, personality disorders, autism spectrum disorders, pain, traumatic brain injury, vascular diseases, substance abuse disorders and/or withdrawal syndromes, and tinnitus.
